This listing includes accelerated approvals (AAs) for malignant hematology and oncology indications that have been granted for supportive care products and changes to dosing or formulation.
Similar Posts
More Spotlight on CDER Science Articles
FDA scientists carry out laboratory, clinical and analytical research to address knowledge gaps in drug development, healthcare technologies and post-market drug monitoring. Spotlight on CDER Science features noteworthy scientific and research-oriented activities conducted within CDER.Boothwyn Pharmacy LLC – 710247 – 06/09/2025
Unapproved New Animal Drug/Adulterated/MisbrandedHeparin Importation
Therefore, in order to ensure that batches of imported heparin continue to meet regulatory standards, FDA is requiring that all lots of Heparin Sodium be required to be in compliance with latest USP specifications.FDA In Brief: Findings from Real-World Data Study Reveal Higher Risk of Hospitalization and Death Among Cancer Patients with COVID-19, Underscore Health Disparities
FDA and Syapse presented Real-World Data at the American Association of Clinical Research (AACR) COVID-19 and Cancer meeting. Findings from study reveal higher risk of hospitalization and death among cancer patients with COVID-19.Nat’s Nuts Issues Allergy Alert on Potential Undeclared Cashews in Nat’s Nuts Brand Cinnamon Whiskey Pecans
Nat’s Nuts of Rochester, NY is recalling 600 bags of Cinnamon Whiskey Pecans, because they may contain undeclared cashews. People who have an allergy or severe sensitivity to cashews run the risk of serious or life-threatening allergic reaction if they consume these products.Superfoods Inc. dba Live it Up. Recalls Live it Up Super Greens Because of Possible Health Risk
Superfoods Inc. DBA as Live it Up of New York, New York is recalling all Live it Up Super Greens, including both Original and Wild Berry flavors, with lots beginning with the letter “A” and all stick pack products due to possible contamination with Salmonella, an organism which can cause serious and